title: New approved nasal naloxone welcome, but unlicensed improvised naloxone spray kits remain a concern: proper scientific study must accompany innovation.
authors.affiliation: Institute of Psychiatry, National Addiction Centre, Psychology and Neuroscience, King's College London, London, UK. john.strang@kcl.ac.uk.
authors.forename: John
authors.initials: J
authors.lastname: Strang
authors.affiliation: Institute of Psychiatry, National Addiction Centre, Psychology and Neuroscience, King's College London, London, UK.
authors.forename: Rebecca
authors.initials: R
authors.lastname: Mcdonald
mesh_terms: D062787:Drug Overdose; D006801:Humans; D009270:Naloxone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*
chemical_list: D009292:Narcotic Antagonists; D009270:Naloxone
keywords: Death; heroin; naloxone; nasal; opioid; overdose